Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

IQPC "Pharmaceutical Patent Litigation Strategies 2008" Conference, London, March 31 - April 1

By Aaron Barkoff

IQPC will be holding its 3rd annual "Pharmaceutical Patent Litigation Strategies" conference in London, March 31 to April 1.

The conference is split into two days--one focusing on European law, the other focusing on U.S. law--and includes an optional third day, with workshops.  The European Focus Day will emphasize proposals for supranational patent litigation; EPLA; and the community patent and how to push it forward.  The U.S. Focus Day will analyze the trends and developments in the pharmaceutical and biotech law sector; the Patent Reform Act 2007; parallel US and European patent litigation strategies; and key rulings.

Margot Fröhlinger, Director, European Commission, will be speaking during the European Focus Day on "How to Achieve Consistency Across European Courts in the Future."  Dr. Fröhlinger leads an exceptional speaker panel that will discuss successful litigation practices and a changing regulatory framework in order to provide superior practical intelligence.

IQPC's 3rd annual "Pharmaceutical Patent Litigation Strategies" conference is sharply focused on improving in-house patent litigation for pharmaceutical companies.  The event will feature the latest updates from both in-house experts and outside counsel.  Key issues to be covered include the link between regulations and actual litigation practices; international litigation processes; patent life extension; and new industry developments.

For more information or to register, please visit the conference website.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on January 20, 2008 (boomark / email).